Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.
Jun 29, 2020
0
178
(HealthDay)—Retinal vein occlusion (RVO) is associated with an increased risk for cardiovascular events and all-cause mortality, according to a review published in the September issue of Retina.
Sep 9, 2019
0
3
A clot in the retinal vein can lead to severe and irreversible loss of vision. In a report in the American Journal of Pathology investigators utilize a newly developed model of central retinal vein occlusion (CRVO) in mice ...
Jan 15, 2019
0
1
The brain is not only able to finish the sentences of others: A study by the Basque research centre BCBL has shown for the first time that it can also anticipate an auditory stimulus and determine the phonemes and specific ...
Sep 18, 2018
0
2169
(HealthDay)—Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment is not associated with increased risk of systemic adverse events for patients with neovascular age-related macular degeneration, diabetic ...
Mar 26, 2018
0
2
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...
Jan 3, 2018
0
6
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National ...
May 9, 2017
0
0
Ischemic disorders of the retina are a frequent cause of blindness. The surrounding cellular protein scaffold might play a crucial role in this process.
Mar 15, 2017
0
2
Eye surgeons at University Hospitals Leuven have been the first to use a surgical robot to operate on a patient with retinal vein occlusion. The robot uses a needle of barely 0.03 millimetre to inject a thrombolytic drug ...
Jan 26, 2017
0
8
(HealthDay)—A case of central retinal vein occlusion (CRVO) two days after phendimetrazine use has been documented and published online Feb. 4 in JAMA Ophthalmology.
Feb 8, 2016
0
0
